C9399 |
UNCLASSIFIED DRUGS OR BIOLOGICALS |
Rebif® (Interferon Beta–1A, 1 mcg) |
07/16/2017 |
N/A |
Apparent on its Face |
C9399 |
UNCLASSIFIED DRUGS OR BIOLOGICALS |
Tesamorelin (Egrifta ™) |
07/16/2017 |
N/A |
Apparent on its Face |
C9399 |
UNCLASSIFIED DRUGS OR BIOLOGICALS |
Sogroya® (somapacitan-beco) |
11/15/2021 |
N/A |
Apparent on its Face |
C9399 |
UNCLASSIFIED DRUGS OR BIOLOGICALS |
Pasireotide (Signifor®) |
11/15/2021 |
N/A |
Apparent on its Face |
C9399 |
UNCLASSIFIED DRUGS OR BIOLOGICALS |
Risankizumab-rzaa
(Skyrizi™)
subcutaneous use* |
01/12/2020 |
N/A |
Apparent on its Face |
C9399 |
UNCLASSIFIED DRUGS OR BIOLOGICALS |
ofatumumab (Kesimpta®)
subcutaneous use* |
07/24/2022 |
N/A |
Apparent on its Face |
C9399 |
UNCLASSIFIED DRUGS OR BIOLOGICALS |
tralokinumab-idrm (Adbry™) |
11/13/2022 |
N/A |
Apparent on its Face |
C9399 |
UNCLASSIFIED DRUGS OR BIOLOGICALS |
All insulin products |
12/11/2022 |
N/A |
Apparent on its Face |
C9399 |
UNCLASSIFIED DRUGS OR BIOLOGICALS |
tirzepatide
(Mounjaro™) |
12/11/2022 |
N/A |
Apparent on its Face |
C9399 |
UNCLASSIFIED DRUGS OR BIOLOGICALS |
Adalimumab-aacf (Idacio®), Adalimumab-afzb (Abrilada™), Adalimumab-bwwd (Hadlima), Adalimumab-fkjp (Hulio®), Adalimumab-adaz (Hyrimoz), Adalimumab-aqvh (Yusimry) |
06/25/2023 |
N/A |
Apparent on its Face |
C9399 |
UNCLASSIFIED DRUGS OR BIOLOGICALS |
secukinumab (Cosentyx™)* |
06/15/2015 |
N/A |
Apparent on its Face |
C9399 |
UNCLASSIFIED DRUGS OR BIOLOGICALS |
Vedolizumab (Entyvio ®) subcutaneous use* |
01/14/2024 |
N/A |
Apparent on its Face |
C9399 |
UNCLASSIFIED DRUGS OR BIOLOGICALS |
adalimumab-aaty (Yuflyma ®) |
01/14/2024 |
N/A |
Apparent on its Face |
C9399 |
UNCLASSIFIED DRUGS OR BIOLOGICALS |
Semaglutide (Wegovy®) |
06/30/2024 |
N/A |
Apparent on its Face |
C9399 |
UNCLASSIFIED DRUGS OR BIOLOGICALS |
Semaglutide (Ozempic®) |
04/01/2024 |
N/A |
Apparent on its Face |
C9399 |
UNCLASSIFIED DRUGS OR BIOLOGICALS |
Tirzepatide (Zepbound™) |
06/30/2024 |
N/A |
Apparent on its Face |
C9399 |
UNCLASSIFIED DRUGS OR BIOLOGICALS |
Liraglutide (Saxenda®) |
06/15/2016 |
N/A |
Apparent on its Face |
C9399 |
UNCLASSIFIED DRUGS OR BIOLOGICALS |
Liraglutide (Victoza®) |
10/16/2011 |
N/A |
Apparent on its Face |
J0129 |
INJECTION, ABATACEPT, 10 MG (CODE MAY BE USED FOR MEDICARE WHEN DRUG ADMINISTERED UNDER THE DIRECT SUPERVISION OF A PHYSICIAN, NOT FOR USE WHEN DRUG IS SELF ADMINISTERED) |
Orencia®
subcutaneous use* |
04/01/2021 |
N/A |
Apparent on its Face |
J0135 |
INJECTION, ADALIMUMAB, 20 MG |
Humira |
02/01/2008 |
N/A |
Apparent on its Face |
J0270 |
INJECTION, ALPROSTADIL, 1.25 MCG (CODE MAY BE USED FOR MEDICARE WHEN DRUG ADMINISTERED UNDER THE DIRECT SUPERVISION OF A PHYSICIAN, NOT FOR USE WHEN DRUG IS SELF ADMINISTERED) |
Caverject, Edex |
02/01/2008 |
N/A |
Apparent on its Face |
J0364 |
INJECTION, APOMORPHINE HYDROCHLORIDE, 1 MG |
Apokyn® |
04/01/2021 |
N/A |
Apparent on its Face |
J0490 |
INJECTION, BELIMUMAB, 10 MG |
Benlysta®, subcutaneous use* |
04/01/2021 |
N/A |
Apparent on its Face |
J0593 |
INJECTION, LANADELUMAB-FLYO, 1 MG (CODE MAY BE USED FOR MEDICARE WHEN DRUG ADMINISTERED UNDER DIRECT SUPERVISION OF A PHYSICIAN, NOT FOR USE WHEN DRUG IS SELF-ADMINISTERED) |
Takhzyro® |
12/02/2019 |
N/A |
Apparent on its Face |
J0599 |
INJECTION, C-1 ESTERASE INHIBITOR (HUMAN), (HAEGARDA), 10 UNITS |
Haegarda® |
01/01/2019 |
N/A |
Apparent on its Face |
J0630 |
INJECTION, CALCITONIN SALMON, UP TO 400 UNITS |
Calcimar, Miacalcin |
02/01/2008 |
N/A |
Apparent on its Face |
J0801 |
INJECTION, CORTICOTROPIN (ACTHAR GEL), UP TO 40 UNITS |
H.P. Acthar® Gel subcutaneous use** |
10/01/2023 |
N/A |
Apparent on its Face |
J0802 |
INJECTION, CORTICOTROPIN (ANI), UP TO 40 UNITS |
Purified Cortrophin Gel® subcutaneous use** |
10/01/2023 |
N/A |
Apparent on its Face |
J1324 |
INJECTION, ENFUVIRTIDE, 1 MG |
Fuzeon |
02/01/2008 |
N/A |
Apparent on its Face |
J1438 |
INJECTION, ETANERCEPT, 25 MG (CODE MAY BE USED FOR MEDICARE WHEN DRUG ADMINISTERED UNDER THE DIRECT SUPERVISION OF A PHYSICIAN, NOT FOR USE WHEN DRUG IS SELF ADMINISTERED) |
Enbrel |
02/01/2008 |
N/A |
Apparent on its Face |
J1595 |
INJECTION, GLATIRAMER ACETATE, 20 MG |
Copaxone™ |
02/01/2008 |
N/A |
Apparent on its Face |
J1628 |
INJECTION, GUSELKUMAB, 1 MG |
Tremfya® (guselkumab) |
04/01/2021 |
N/A |
Apparent on its Face |
J1675 |
INJECTION, HISTRELIN ACETATE, 10 MICROGRAMS |
Supprelin LA™ |
02/01/2008 |
N/A |
Apparent on its Face |
J1744 |
INJECTION, ICATIBANT, 1 MG |
Firazyr™ |
11/15/2011 |
N/A |
Apparent on its Face |
J1748 |
INJECTION, INFLIXIMAB-DYYB (ZYMFENTRA), 10 MG |
Infliximab-dyyb (Zymfentra) |
08/18/2024 |
N/A |
Apparent on its Face |
J1811 |
INSULIN (FIASP) FOR ADMINISTRATION THROUGH DME (I.E., INSULIN PUMP) PER 50 UNITS |
Fiasp® for insulin pump use |
09/03/2023 |
N/A |
Apparent on its Face |
J1812 |
INSULIN (FIASP), PER 5 UNITS |
Fiasp® injection* |
09/03/2023 |
N/A |
Apparent on its Face |
J1813 |
INSULIN (LYUMJEV) FOR ADMINISTRATION THROUGH DME (I.E., INSULIN PUMP) PER 50 UNITS |
Lyumjev® for insulin pump use |
09/03/2023 |
N/A |
Apparent on its Face |
J1814 |
INSULIN (LYUMJEV), PER 5 UNITS |
Lyumjev® injection* |
09/03/2023 |
N/A |
Apparent on its Face |
J1815 |
INJECTION, INSULIN, PER 5 UNITS |
Humalog, Humulin, Iletin, Insulin Lispro, Novo Nordisk, NPH, Pork Insulin, Regular Insulin, Ultralente, Velosulin, Humulin R, Iletin II Regular Port, Insulin Purified Pork, ReliOn, Lente Iletin I, Novolin R, Humulin R U-500 |
02/01/2008 |
N/A |
Apparent on its Face |
J1815 |
INJECTION, INSULIN, PER 5 UNITS |
All insulin products |
12/11/2022 |
N/A |
Apparent on its Face |
J1817 |
INSULIN FOR ADMINISTRATION THROUGH DME (I.E., INSULIN PUMP) PER 50 UNITS |
All insulin products |
12/11/2022 |
N/A |
Apparent on its Face |
J1817 |
INSULIN FOR ADMINISTRATION THROUGH DME (I.E., INSULIN PUMP) PER 50 UNITS |
Humalog, Humulin, Vesolin BR, Iletin II NPH Pork, Lantus, Lispro-PFC, Novolin, Novolog, Novolog Flexpen, Novolog Mix, ReliOn Novolin |
02/01/2008 |
N/A |
Apparent on its Face |
J1826 |
INJECTION, INTERFERON BETA-1A, 30 MCG |
Avonex Pen®, Rebif®, Rebif® Rebidose® |
11/15/2021 |
N/A |
Apparent on its Face |
J1830 |
INJECTION, INTERFERON BETA-1B, 0.25 MG (CODE MAY BE USED FOR MEDICARE WHEN DRUG ADMINISTERED UNDER THE DIRECT SUPERVISION OF A PHYSICIAN, NOT FOR USE WHEN DRUG IS SELF ADMINISTERED) |
Betaseron™ |
02/01/2008 |
N/A |
Apparent on its Face |
J1941 |
INJECTION, FUROSEMIDE (FUROSCIX), 20 MG |
Furoscix® |
09/03/2023 |
N/A |
Apparent on its Face |
J2170 |
INJECTION, MECASERMIN, 1 MG |
Iplex ™ Increlex™ |
02/01/2008 |
N/A |
Apparent on its Face |
J2212 |
INJECTION, METHYLNALTREXONE, 0.1 MG |
Relistor ™ |
02/15/2013 |
N/A |
Apparent on its Face |
J2267 |
INJECTION, MIRIKIZUMAB-MRKZ, 1 MG |
mirikizumab-mrkz (Omvoh™) subcutaneous use* |
07/01/2024 |
N/A |
Apparent on its Face |
J2354 |
INJECTION, OCTREOTIDE, NON-DEPOT FORM FOR SUBCUTANEOUS OR INTRAVENOUS INJECTION, 25 MCG |
Sandostatin™, subcutaneous use* |
02/01/2008 |
N/A |
Apparent on its Face |
J2440 |
INJECTION, PAPAVERINE HCL, UP TO 60 MG |
Papaverine HCL |
02/01/2008 |
N/A |
Apparent on its Face |
J2940 |
INJECTION, SOMATREM, 1 MG |
Protropin™ |
02/01/2008 |
N/A |
Apparent on its Face |
J2941 |
INJECTION, SOMATROPIN, 1 MG |
Genotropin™
|
02/01/2008 |
N/A |
Apparent on its Face |
J3030 |
INJECTION, SUMATRIPTAN SUCCINATE, 6 MG (CODE MAY BE USED FOR MEDICARE WHEN DRUG ADMINISTERED UNDER THE DIRECT SUPERVISION OF A PHYSICIAN, NOT FOR USE WHEN DRUG IS SELF ADMINISTERED) |
Imitrex™
|
02/01/2008 |
N/A |
Apparent on its Face |
J3031 |
INJECTION, FREMANEZUMAB-VFRM, 1 MG (CODE MAY BE USED FOR MEDICARE WHEN DRUG ADMINISTERED UNDER THE DIRECT SUPERVISION OF A PHYSICIAN, NOT FOR USE WHEN DRUG IS SELF-ADMINISTERED) |
Ajovy™ |
04/01/2021 |
N/A |
Apparent on its Face |
J3110 |
INJECTION, TERIPARATIDE, 10 MCG |
Forteo™ |
02/01/2008 |
N/A |
Apparent on its Face |
J3355 |
INJECTION, UROFOLLITROPIN, 75 IU |
Metrodin, Bravelle, Fertinex |
02/01/2008 |
N/A |
Apparent on its Face |
J3357 |
USTEKINUMAB, FOR SUBCUTANEOUS INJECTION, 1 MG |
Stelara® |
11/15/2021 |
N/A |
Apparent on its Face |
J3490 |
UNCLASSIFIED DRUGS |
Tirzepatide (Zepbound™) |
06/30/2024 |
N/A |
Apparent on its Face |
J3490 |
UNCLASSIFIED DRUGS |
Sogroya® (somapacitan-beco) |
11/15/2021 |
N/A |
Apparent on its Face |
J3490 |
UNCLASSIFIED DRUGS |
Abaloparatide
(Tymlos™) |
07/16/2018 |
N/A |
Apparent on its Face |
J3490 |
UNCLASSIFIED DRUGS |
Albiglutide (Tanzeum™) |
06/15/2016 |
N/A |
Apparent on its Face |
J3490 |
UNCLASSIFIED DRUGS |
Alirocumab (Praulent™) |
06/15/2016 |
N/A |
Apparent on its Face |
J3490 |
UNCLASSIFIED DRUGS |
Dulaglutide (Trulicity™) |
06/15/2016 |
N/A |
Apparent on its Face |
J3490 |
UNCLASSIFIED DRUGS |
etanercept-szzs (Erelzi) |
11/15/2016 |
N/A |
Apparent on its Face |
J3490 |
UNCLASSIFIED DRUGS |
Evolocumab (Repatha™) |
06/15/2016 |
N/A |
Apparent on its Face |
J3490 |
UNCLASSIFIED DRUGS |
Insulin Glargine (Toujeo SoloStar™) |
06/15/2016 |
N/A |
Apparent on its Face |
J3490 |
UNCLASSIFIED DRUGS |
Insulin Glargine (Lantus SoloStar™) |
06/15/2016 |
N/A |
Apparent on its Face |
J3490 |
UNCLASSIFIED DRUGS |
Sarilumab (Kevzara™) |
04/01/2021 |
N/A |
Apparent on its Face |
J3490 |
UNCLASSIFIED DRUGS |
Ixekizumab (Taltz™) |
06/15/2016 |
N/A |
Apparent on its Face |
J3490 |
UNCLASSIFIED DRUGS |
Liraglutide (Victoza ™) |
10/16/2011 |
N/A |
Apparent on its Face |
J3490 |
UNCLASSIFIED DRUGS |
Liraglutide (Saxenda™) |
06/15/2016 |
N/A |
Apparent on its Face |
J3490 |
UNCLASSIFIED DRUGS |
Methotrexate (Rasuvo™) |
06/15/2016 |
N/A |
Apparent on its Face |
J3490 |
UNCLASSIFIED DRUGS |
Methotrexate (Otrexup™) |
06/15/2016 |
N/A |
Apparent on its Face |
J3490 |
UNCLASSIFIED DRUGS |
Metreleptin (Myalept™) |
06/15/2016 |
N/A |
Apparent on its Face |
J3490 |
UNCLASSIFIED DRUGS |
Mipomersen sodium (Kynamro™) |
09/15/2013 |
N/A |
Apparent on its Face |
J3490 |
UNCLASSIFIED DRUGS |
Parathyroid hormone (Natpara™) |
06/15/2016 |
N/A |
Apparent on its Face |
J3490 |
UNCLASSIFIED DRUGS |
Pasireotide (Signifor™) |
06/15/2016 |
N/A |
Apparent on its Face |
J3490 |
UNCLASSIFIED DRUGS |
Peginterferon beta-1a (Plegridy™)
|
06/15/2016 |
N/A |
Apparent on its Face |
J3490 |
UNCLASSIFIED DRUGS |
Pramlintide (Symlin™) |
02/01/2008 |
N/A |
Apparent on its Face |
J3490 |
UNCLASSIFIED DRUGS |
Rebif® (Interferon Beta–1A, 1 mcg) |
07/16/2017 |
N/A |
Apparent on its Face |
J3490 |
UNCLASSIFIED DRUGS |
Tesamorelin (Egrifta™) |
10/16/2011 |
N/A |
Apparent on its Face |
J3490 |
UNCLASSIFIED DRUGS |
TriMix™ |
10/16/2011 |
N/A |
Apparent on its Face |
J3490 |
UNCLASSIFIED DRUGS |
Quadmix (+ Atropine) |
07/16/2017 |
N/A |
Apparent on its Face |
J3490 |
UNCLASSIFIED DRUGS |
Adalimumab-atto (AMJEVITA™) |
02/15/2017 |
N/A |
Apparent on its Face |
J3490 |
UNCLASSIFIED DRUGS |
Golimumab (SIMPONI) |
02/15/2017 |
N/A |
Apparent on its Face |
J3490 |
UNCLASSIFIED DRUGS |
Risankizumab-rzaa
(Skyrizi™)
subcutaneous use* |
01/12/2020 |
N/A |
Apparent on its Face |
J3490 |
UNCLASSIFIED DRUGS |
ofatumumab (Kesimpta®)
subcutaneous use* |
07/24/2022 |
N/A |
Apparent on its Face |
J3490 |
UNCLASSIFIED DRUGS |
tralokinumab-idrm (Adbry™) |
11/13/2022 |
N/A |
Apparent on its Face |
J3490 |
UNCLASSIFIED DRUGS |
All insulin products |
12/11/2022 |
N/A |
Apparent on its Face |
J3490 |
UNCLASSIFIED DRUGS |
tirzepatide
(Mounjaro™) |
12/11/2022 |
N/A |
Apparent on its Face |
J3490 |
UNCLASSIFIED DRUGS |
Adalimumab-aacf (Idacio®), Adalimumab-afzb (Abrilada™), Adalimumab-bwwd (Hadlima), Adalimumab-fkjp (Hulio®), Adalimumab-adaz (Hyrimoz), Adalimumab-aqvh (Yusimry) |
06/25/2023 |
N/A |
Apparent on its Face |
J3490 |
UNCLASSIFIED DRUGS |
secukinumab (Cosentyx ™)* |
06/15/2015 |
N/A |
Apparent on its Face |
J3490 |
UNCLASSIFIED DRUGS |
Vedolizumab (Entyvio ®) subcutaneous use* |
01/14/2024 |
N/A |
Apparent on its Face |
J3490 |
UNCLASSIFIED DRUGS |
adalimumab-aaty (Yuflyma ®) |
01/14/2024 |
N/A |
Apparent on its Face |
J3590 |
UNCLASSIFIED BIOLOGICS |
adalimumab-aaty (Yuflyma ®) |
01/14/2024 |
N/A |
Apparent on its Face |
J3590 |
UNCLASSIFIED BIOLOGICS |
Vedolizumab (Entyvio ®) subcutaneous use* |
01/14/2024 |
N/A |
Apparent on its Face |
J3590 |
UNCLASSIFIED BIOLOGICS |
Adalimumab-aacf (Idacio®), Adalimumab-afzb (Abrilada™), Adalimumab-bwwd (Hadlima), Adalimumab-fkjp (Hulio®), Adalimumab-adaz (Hyrimoz), Adalimumab-aqvh (Yusimry) |
06/25/2023 |
N/A |
Apparent on its Face |
J3590 |
UNCLASSIFIED BIOLOGICS |
All insulin products |
12/11/2022 |
N/A |
Apparent on its Face |
J3590 |
UNCLASSIFIED BIOLOGICS |
tirzepatide
(Mounjaro™) |
12/11/2022 |
N/A |
Apparent on its Face |
J3590 |
UNCLASSIFIED BIOLOGICS |
tralokinumab-idrm (Adbry™) |
11/13/2022 |
N/A |
Apparent on its Face |
J3590 |
UNCLASSIFIED BIOLOGICS |
ofatumumab (Kesimpta®)
subcutaneous use* |
07/24/2022 |
N/A |
Apparent on its Face |
J3590 |
UNCLASSIFIED BIOLOGICS |
adalimumab-adbm
(Cyltezo™ ) |
04/01/2021 |
N/A |
Apparent on its Face |
J3590 |
UNCLASSIFIED BIOLOGICS |
Anakinra (Kineret ™) |
02/01/2008 |
N/A |
Apparent on its Face |
J3590 |
UNCLASSIFIED BIOLOGICS |
Asfotase-alfa (Strensiq®) |
04/01/2021 |
N/A |
Apparent on its Face |
J3590 |
UNCLASSIFIED BIOLOGICS |
Brodalumab (Siliq) |
07/16/2017 |
N/A |
Apparent on its Face |
J3590 |
UNCLASSIFIED BIOLOGICS |
Dupilumab (Dupixent) |
07/16/2017 |
N/A |
Apparent on its Face |
J3590 |
UNCLASSIFIED BIOLOGICS |
erenumab-aooe
(Aimovig™) |
04/01/2021 |
N/A |
Apparent on its Face |
J3590 |
UNCLASSIFIED BIOLOGICS |
Exenatide,(Byetta ™)
|
10/16/2008 |
N/A |
Apparent on its Face |
J3590 |
UNCLASSIFIED BIOLOGICS |
Exenatide (Bydureon™) |
06/15/2016 |
N/A |
Apparent on its Face |
J3590 |
UNCLASSIFIED BIOLOGICS |
Galcenezumab-gnlm (Emgality™) |
04/01/2021 |
N/A |
Apparent on its Face |
J3590 |
UNCLASSIFIED BIOLOGICS |
Peginterferon alfa-2b, (Pegintron™ Sylatron™) |
02/01/2008 |
N/A |
Apparent on its Face |
J3590 |
UNCLASSIFIED BIOLOGICS |
Pegvisomant, (Somavert™ ) |
02/01/2008 |
N/A |
Apparent on its Face |
J3590 |
UNCLASSIFIED BIOLOGICS |
Rebif® (Interferon Beta–1A, 1 mcg) |
07/16/2017 |
N/A |
Apparent on its Face |
J3590 |
UNCLASSIFIED BIOLOGICS |
Sarilumab (Kevzara®) |
04/01/2021 |
N/A |
Apparent on its Face |
J3590 |
UNCLASSIFIED BIOLOGICS |
secukinumab (Cosentyx ™)* |
06/15/2015 |
N/A |
Apparent on its Face |
J3590 |
UNCLASSIFIED BIOLOGICS |
Semaglutide (Ozempic®) |
04/01/2021 |
N/A |
Apparent on its Face |
J3590 |
UNCLASSIFIED BIOLOGICS |
Risankizumab-rzaa
(Skyrizi™)
subcutaneous use* |
01/12/2020 |
N/A |
Apparent on its Face |
J3590 |
UNCLASSIFIED BIOLOGICS |
Sogroya® (somapacitan-beco) |
11/15/2021 |
N/A |
Apparent on its Face |
J3590 |
UNCLASSIFIED BIOLOGICS |
Ropeginterferon alfa-2b-njft (BESREMI®) |
04/24/2022 |
N/A |
Apparent on its Face |
J3590 |
UNCLASSIFIED BIOLOGICS |
Semaglutide (Wegovy®) |
06/30/2024 |
N/A |
Apparent on its Face |
J3590 |
UNCLASSIFIED BIOLOGICS |
Tirzepatide (Zepbound™) |
06/30/2024 |
N/A |
Apparent on its Face |
J3590 |
UNCLASSIFIED BIOLOGICS |
Liraglutide (Saxenda®) |
06/15/2016 |
N/A |
Apparent on its Face |
J3590 |
UNCLASSIFIED BIOLOGICS |
Liraglutide (Victoza®) |
10/16/2011 |
N/A |
Apparent on its Face |
J9212 |
INJECTION, INTERFERON ALFACON-1, RECOMBINANT, 1 MICROGRAM |
Infergen |
02/01/2008 |
N/A |
Apparent on its Face |
J9213 |
INJECTION, INTERFERON, ALFA-2A, RECOMBINANT, 3 MILLION UNITS |
Peginterferon alfa-2a, (Pegasys ®, Pegasys ® Proclick™) |
02/15/2013 |
N/A |
Apparent on its Face |
J9216 |
INJECTION, INTERFERON, GAMMA 1-B, 3 MILLION UNITS |
Actimmune™ |
02/01/2008 |
N/A |
Apparent on its Face |
J9218 |
LEUPROLIDE ACETATE, PER 1 MG |
Lupron™ |
02/01/2008 |
N/A |
Apparent on its Face |
Q3027 |
INJECTION, INTERFERON BETA-1A, 1 MCG FOR INTRAMUSCULAR USE |
Avonex™ |
01/01/2014 |
N/A |
Apparent on its Face |
Q3028 |
INJECTION, INTERFERON BETA-1A, 1 MCG FOR SUBCUTANEOUS USE |
Rebif™ |
01/01/2014 |
N/A |
Apparent on its Face |
Q5131 |
INJECTION, ADALIMUMAB-AACF (IDACIO), BIOSIMILAR, 20 MG |
Idacio® |
09/03/2023 |
N/A |
Apparent on its Face |
Q5132 |
INJECTION, ADALIMUMAB-AFZB (ABRILADA), BIOSIMILAR, 10 MG |
ABRILADA™ |
06/25/2023 |
N/A |
Apparent on its Face |
Q5137 |
INJECTION, USTEKINUMAB-AUUB (WEZLANA), BIOSIMILAR, SUBCUTANEOUS, 1 MG |
ustekinumab-auub (Wezlana™) subcutaneous use* |
07/01/2024 |
N/A |
Apparent on its Face |